Gasparin, Aléxia Thamara
Araujo, Claudiane Isabel Franco
Schmitt, Patricia
Cardoso, Mônica Ribas
Perussolo, Maiara Carolina
de Jesus, Thainá Caroline Schuartz
Santiago, Erika Bergamo
Silva, Ivan Lucas Reis
de Sousa, Ricardo Gurgel
Teng, Flavia Zhu
Severo, Evair Borges
Ribeiro, Victor Henrique Alves
Cardoso, Milena Andreuzo
Silva, Fernanda D’Amico
de Araujo Perazzoli, Carolina Rodrigues
de Holanda Farias, João Samuel
de Almeida, Bernardo Montesanti Machado
Rogal Júnior, Sergio Renato
Figueredo, Marcus Vinícius Mazega
Funding for this research was provided by:
Hilab
Article History
Received: 14 March 2022
Accepted: 30 May 2022
First Online: 21 June 2022
Competing interests
: M. V. M. Figueredo is the CEO at Hilab; S. R. Rogal Júnior is the CTO at Hilab; A. T. Gasparin is microscopy manager at Hilab; C. I. F. Araujo, P. Schmitt, M. R. Cardoso, M. C. Perussolo, and T. C. S. Jesus are health researchers at Hilab; E. B. Santiago is R&D manager at Hilab; I. L. R. Silva is head of R&D at Hilab; R. G. Souza and F. Z. Teng are R&D researchers at Hilab; E. B. Severo is computer vision engineer at Hilab; V. H. A. Ribeiro is head of A.I at Hilab; M. A. Cardoso and F. D. Silva are A.I researchers at Hilab; C. R. A. Perazzoli is marketing analyst at Hilab; J. S. H. Farias is assistant doctor at Erasto Gaertner Hospital; B. M. M. Almeida is medical director at Hilab.